Constellation Brands Slides to 52-Week Low as Analysts Cut Targets
Evercore cut its STZ target to $160 as the Corona and Modelo owner trades 29% below its high, with tariffs, weak Hispanic demand and Ozempic weighing on beer sales.
By Amara Osei
2 min read
Updated

What's News
- Evercore ISI lowered its STZ price target from $175 to $160 on September 21, 2026; BNP Paribas and TD Cowen also trimmed targets.
- STZ trades at $118.39, about 29% below its 52-week high of $168.60, near a decade-low valuation of about 11x earnings with a 3.5% dividend.
- Constellation reports earnings on October 6, 2026, after withdrawing its fiscal 2028 outlook earlier this year.
Evercore ISI cut its price target on Constellation Brands (NYSE: STZ) from $175 to $160 on September 21, 2026 — the latest in a series of reductions that includes trims from BNP Paribas and TD Cowen around the same time.
The stock now trades at $118.39, near its 52-week low and roughly 29% below its 52-week high of $168.60. The company owns the US rights to Corona, Modelo Especial and Pacífico — the imported beer brands that dominate American bar tops.
The pressure comes from three directions.
Tariffs on aluminum. The beer Constellation brews in Mexico is largely exempt from tariffs, but the aluminum cans it ships in are taxed, raising costs. BNP Paribas and TD Cowen flagged similar concerns when they lowered their targets.
A shrinking core customer base. About half of Constellation's beer sales come from Hispanic drinkers. Amid job worries and immigration fears, their consumption has declined. No marketing campaign fixes that.
Falling alcohol consumption overall. Weight-loss drugs like Ozempic curb the urge to drink, and younger adults order fewer beers. Management acknowledged the deteriorating picture earlier this year by withdrawing its fiscal 2028 outlook.
The Bull Case: A Decade-Low Valuation
Bulls argue investors are getting the leading US beer portfolio at a discount. Modelo Especial is the best-selling beer in America. Corona and Pacífico retain loyal fans at premium prices. Beer generates 80% of revenue, and Constellation's brands are among the few that consumers ask for by name.
The valuation supports the bull argument. At roughly 11 times earnings, the stock trades near its lowest multiple in a decade and pays a 3.5% dividend while shareholders wait for a turnaround.
Institutional money has not fled. Insider Monkey data shows 59 hedge funds held STZ in the second quarter of 2026, up from 56 in the first quarter.
The Bear Case: The Market Knows Something
Bears read the same numbers as a warning. Tariffs on cans may persist as long as trade tensions do. The pullback among Hispanic customers ties to jobs and immigration — forces beyond any company's control. Beer consumption keeps falling steadily as weight-loss drugs and diet routines spread.
Their sharpest point: sales at a premium brand can slide for longer than a cheap multiple suggests. A low price is not a floor if demand keeps eroding.
The Bottom Line
Both cases rest on the same figure — 11 times earnings. Bulls see the owner of America's most popular beer brands available near an all-time low, with a 3.5% dividend cushioning the wait. Bears see the market pricing in years of declining demand that tariffs and changing habits could make permanent.
The next test arrives soon. Constellation reports earnings on October 6, 2026, and the results will show whether beer volumes have stabilized and whether tariff costs are steadying — the two data points that will determine which case the market believes.
Source: Yahoo Finance
More from Amara Osei
Show full bio
Senior reporter covering consumer brands and retail at Business Bearings.
230 articles